Comparison of survival of patients with heart and lung transplants on peritoneal dialysis and hemodialysis.
作者信息
Guru Pramod, Prakash Rachita, Sheth Heena, Bender Filitsa, Burr Renee, Piraino Beth
机构信息
University of Pittsburgh School of Medicine 518 Scaife Hall, Pittsburgh, PA.
University of Pittsburgh School of Medicine 518 Scaife Hall, Pittsburgh, PA
出版信息
Perit Dial Int. 2015 Jan-Feb;35(1):98-101. doi: 10.3747/pdi.2013.00299.
Abstract
摘要
相似文献
1
Comparison of survival of patients with heart and lung transplants on peritoneal dialysis and hemodialysis.接受心脏和肺移植的患者在腹膜透析和血液透析情况下的生存情况比较。
Perit Dial Int. 2015 Jan-Feb;35(1):98-101. doi: 10.3747/pdi.2013.00299.
2
Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.适合两种治疗模式的患者中，血液透析与腹膜透析患者的生存比较。
Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.
3
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.使用碱性磷酸酶和甲状旁腺激素对腹膜透析和血液透析患者进行死亡率预测的比较
Perit Dial Int. 2014 Nov-Dec;34(7):732-48. doi: 10.3747/pdi.2013.00110. Epub 2014 Jan 2.
4
Peritoneal dialysis as the first-choice treatment.腹膜透析作为首选治疗方法。
Contrib Nephrol. 2003(140):218-25. doi: 10.1159/000071394.
5
Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure.终末期肾病合并充血性心力衰竭患者行血液透析相对腹膜透析的生存优势。
Kidney Int. 2011 Nov;80(9):970-977. doi: 10.1038/ki.2011.233. Epub 2011 Jul 20.
6
Death risk predictors among peritoneal dialysis and hemodialysis patients: a preliminary comparison.腹膜透析和血液透析患者的死亡风险预测因素：初步比较
Am J Kidney Dis. 1995 Jul;26(1):220-8. doi: 10.1016/0272-6386(95)90177-9.
7
Comparison of Subdural Hematoma Risk between Hemodialysis and Peritoneal Dialysis Patients with ESRD.终末期肾病血液透析与腹膜透析患者硬膜下血肿风险的比较。
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):994-1001. doi: 10.2215/CJN.08140814. Epub 2015 Mar 30.
8
Comparing mortality in renal patients on hemodialysis versus peritoneal dialysis using a marginal structural model.使用边际结构模型比较接受血液透析与腹膜透析的肾病患者的死亡率。
Int J Biostat. 2010;6(1):Article 2. doi: 10.2202/1557-4679.1166.
9
Mortality in Incident Maintenance Dialysis Patients Versus Incident Solid Organ Cancer Patients: A Population-Based Cohort.维持性透析患者与实体器官恶性肿瘤患者的死亡率比较：一项基于人群的队列研究。
Am J Kidney Dis. 2019 Jun;73(6):765-776. doi: 10.1053/j.ajkd.2018.12.011. Epub 2019 Feb 6.
10
The Effect of Automated Versus Continuous Ambulatory Peritoneal Dialysis on Mortality Risk In China.自动化腹膜透析与持续性非卧床腹膜透析对中国患者死亡风险的影响
Perit Dial Int. 2018 Dec;38(Suppl 2):S25-S35. doi: 10.3747/pdi.2017.00235. Epub 2018 Oct 12.
引用本文的文献
1
Peritoneal Dialysis After Liver Transplantation: A Systematic Review.肝移植后腹膜透析：一项系统评价
Can J Kidney Health Dis. 2021 Jul 18;8:20543581211029722. doi: 10.1177/20543581211029722. eCollection 2021.
本文引用的文献
1
Home dialysis is a successful strategy in nonrenal solid organ transplant recipients with end-stage renal disease.家庭透析是终末期肾病的非肾实体器官移植受者的一种成功策略。
Nephrol Dial Transplant. 2010 Oct;25(10):3425-9. doi: 10.1093/ndt/gfq373. Epub 2010 Jun 24.
2
Peritoneal dialysis after nonrenal solid organ transplantation: clinical outcomes and practical considerations.非肾实体器官移植后腹膜透析：临床结局与实际考量。
Perit Dial Int. 2010 Jan-Feb;30(1):7-12. doi: 10.3747/pdi.2008.00215.
3
Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease.对于终末期肾病的心脏移植受者，腹膜透析相较于血液透析的优势。
Int Urol Nephrol. 2008;40(4):1083-7. doi: 10.1007/s11255-008-9406-z. Epub 2008 Jun 14.
4
Chronic kidney disease after nonrenal solid-organ transplantation.非肾实体器官移植后的慢性肾脏病
J Am Soc Nephrol. 2007 Dec;18(12):3031-41. doi: 10.1681/ASN.2007040394.
5
The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR).终末期肾病发生后心脏移植受者的结局：加拿大器官替代登记处（CORR）分析
Am J Transplant. 2007 Feb;7(2):461-5. doi: 10.1111/j.1600-6143.2006.01640.x.
6
Chronic renal failure after transplantation of a nonrenal organ.非肾器官移植后的慢性肾衰竭
N Engl J Med. 2003 Sep 4;349(10):931-40. doi: 10.1056/NEJMoa021744.
7
Outcome in patients with end-stage renal disease following heart or heart--lung transplantation receiving peritoneal dialysis.接受腹膜透析的终末期肾病患者在心脏或心肺移植后的结局
Nephrol Dial Transplant. 2001 Aug;16(8):1681-5. doi: 10.1093/ndt/16.8.1681.
8
Patient survival with renal replacement therapy in heart transplantation patients.心脏移植患者接受肾脏替代治疗后的生存情况。
ASAIO J. 1998 Sep-Oct;44(5):M546-8. doi: 10.1097/00002480-199809000-00046.
9
Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression.心脏移植后环孢素相关终末期肾病：发病率与进展
Transplantation. 1997 Mar 15;63(5):664-8. doi: 10.1097/00007890-199703150-00009.
10
Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients.免疫抑制患者持续非卧床腹膜透析的不良预后
Nephrol Dial Transplant. 1996 Jun;11(6):1104-8.
Zotero 插件